138 related articles for article (PubMed ID: 35633306)
41. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
Elliott JA; Doyle SL; Murphy CF; King S; Guinan EM; Beddy P; Ravi N; Reynolds JV
Ann Surg; 2017 Nov; 266(5):822-830. PubMed ID: 28796017
[TBL] [Abstract][Full Text] [Related]
42. Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma.
Chargi N; Bril SI; Swartz JE; Wegner I; Willems SM; de Bree R
Oral Oncol; 2020 Feb; 101():104519. PubMed ID: 31855705
[TBL] [Abstract][Full Text] [Related]
43. Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis.
Surov A; Meyer HJ; Wienke A
Oncology; 2022; 100(9):498-504. PubMed ID: 35817000
[No Abstract] [Full Text] [Related]
44. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review.
Aleixo GFP; Williams GR; Nyrop KA; Muss HB; Shachar SS
Breast Cancer Res Treat; 2019 Oct; 177(3):569-579. PubMed ID: 31292800
[TBL] [Abstract][Full Text] [Related]
45. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
Mayr R; Gierth M; Zeman F; Reiffen M; Seeger P; Wezel F; Pycha A; Comploj E; Bonatti M; Ritter M; van Rhijn BWG; Burger M; Bolenz C; Fritsche HM; Martini T
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):505-513. PubMed ID: 29479839
[TBL] [Abstract][Full Text] [Related]
46. Low skeletal muscle mass predicts treatment response in oncology: a meta-analysis.
Surov A; Strobel A; Borggrefe J; Wienke A
Eur Radiol; 2023 Sep; 33(9):6426-6437. PubMed ID: 36929392
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of low computed tomography-measured skeletal muscle index and handgrip strength in a general medical population.
Van Jacobs A; Coltman A; Gomez-Perez SL; Bienia B; Sclamberg JS; Peterson SJ
Nutr Clin Pract; 2022 Feb; 37(1):102-109. PubMed ID: 33930219
[TBL] [Abstract][Full Text] [Related]
48. Sarcopenia and loss of muscle mass in patients with lung cancer undergoing chemotherapy treatment: a systematic review and meta-analysis.
Jensen S; Bloch Z; Quist M; Hansen TTD; Johansen C; Pappot H; Suetta C; Skjødt Rafn B
Acta Oncol; 2023 Mar; 62(3):318-328. PubMed ID: 37051865
[TBL] [Abstract][Full Text] [Related]
49. Sarcopenia in lung transplantation: a systematic review.
Rozenberg D; Wickerson L; Singer LG; Mathur S
J Heart Lung Transplant; 2014 Dec; 33(12):1203-12. PubMed ID: 25044057
[TBL] [Abstract][Full Text] [Related]
50. CT-defined low-skeletal muscle mass as a prognostic marker for survival in prostate cancer: A systematic review and meta-analysis.
Meyer HJ; Wienke A; Surov A
Urol Oncol; 2022 Mar; 40(3):103.e9-103.e16. PubMed ID: 34483042
[TBL] [Abstract][Full Text] [Related]
51. Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT).
Chan DL; Clarke SJ; Engel A; Diakos CI; Pavlakis N; Roach PJ; Bailey DL; Bauer J; Findlay M
Eur J Clin Nutr; 2022 Jan; 76(1):143-149. PubMed ID: 33986486
[TBL] [Abstract][Full Text] [Related]
52. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
[TBL] [Abstract][Full Text] [Related]
53. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.
Giusto M; Lattanzi B; Albanese C; Galtieri A; Farcomeni A; Giannelli V; Lucidi C; Di Martino M; Catalano C; Merli M
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):328-34. PubMed ID: 25569567
[TBL] [Abstract][Full Text] [Related]
54. Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?
Deluche E; Lachatre D; Di Palma M; Simon H; Tissot V; Vansteene D; Meingan P; Mohebi A; Lenczner G; Pigneur F; Goldwasser F; Raynard B;
Breast; 2022 Feb; 61():84-90. PubMed ID: 34923226
[TBL] [Abstract][Full Text] [Related]
55. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
56. The Association Between Computed Tomography-Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review.
Findlay M; White K; Lai M; Luo D; Bauer JD
J Acad Nutr Diet; 2020 Aug; 120(8):1330-1347.e8. PubMed ID: 32711854
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of Sarcopenia and Its Relationship with Nutritional State and Quality of Life in Patients with Digestive Diseases.
Onishi S; Shiraki M; Nishimura K; Hanai T; Moriwaki H; Shimizu M
J Nutr Sci Vitaminol (Tokyo); 2018; 64(6):445-453. PubMed ID: 30606967
[TBL] [Abstract][Full Text] [Related]
58. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
[TBL] [Abstract][Full Text] [Related]
59. The type of gastrectomy affects skeletal muscle loss and the long-term outcomes of elderly patients with gastric cancer: a retrospective study using computed tomography images.
Okamoto A; Aikou S; Iwata R; Oya S; Kawasaki K; Okumura Y; Yagi K; Yamashita H; Nomura S; Seto Y
Surg Today; 2022 May; 52(5):812-821. PubMed ID: 34837102
[TBL] [Abstract][Full Text] [Related]
60. Preoperative sarcopenia determinants in pancreatic cancer patients.
Carrara G; Pecorelli N; De Cobelli F; Cristel G; Damascelli A; Beretta L; Braga M
Clin Nutr; 2017 Dec; 36(6):1649-1653. PubMed ID: 27789123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
